Integrated BioPharma (OTCMKTS:INBP) Shares Up 2.7% – Still a Buy?

Integrated BioPharma Inc. (OTCMKTS:INBP)’s share price was up 2.7% during mid-day trading on Wednesday . The stock traded as high as $0.2781 and last traded at $0.2781. Approximately 201 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 4,029 shares. The stock had previously closed at $0.2707.

Integrated BioPharma Stock Performance

The firm has a market capitalization of $8.61 million, a price-to-earnings ratio of -13.90 and a beta of 0.55. The stock has a fifty day moving average of $0.30 and a 200-day moving average of $0.31.

Integrated BioPharma (OTCMKTS:INBP) last posted its quarterly earnings results on Wednesday, February 11th. The company reported ($0.03) earnings per share for the quarter. Integrated BioPharma had a negative net margin of 0.40% and a negative return on equity of 1.02%. The company had revenue of $11.28 million during the quarter.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brands, as well as other branded proprietary nutraceutical products.